Resources
Plasmid Files

pFA6a-natMX6

Plasmid for yeast gene deletion using the natMX6 selectable marker conferring nourseothricin resistance.

To see this sequence with restriction sites, features, and translations, please download
 SnapGene or the free  SnapGene Viewer.

pFA6a-natMX6 Sequence and MappFA6a-natMX6.dna
Map and Sequence File   
Sequence Author:  EUROSCARF
Download Free Trial Get SnapGene Viewer

 PvuII (13) NdeI (3619) AatII (3370) ZraI (3368) SspI (3252) XmnI (3047) TsoI (2847) PvuI (2818) BmrI (2488) AlwNI (1971) PspFI (1863) HindIII (17) SalI (35) AccI (36) F1 (40 .. 59) BamHI (41) PacI (56) AscI (61) BglII (68) BstXI (115) BmgBI (151) Bpu10I (160) BseRI (262) NcoI (455) AgeI (485) XcmI (528) PpuMI (539) BbsI (552) PflFI - Tth111I (556) PshAI (700) NruI (844) MreI (856) KasI (868) NarI (869) SfoI (870) PluTI (872) SphI (1020) BstAPI (1022) BsmI (1222) PmeI (1269) Eco53kI (1276) SacI (1278) ApoI - EcoRI (1280) R1 (1266 .. 1285) BspDI - ClaI (1287) EcoRV (1294) SpeI (1304) SfiI (1317) SacII (1324) HpaI (1376) BspQI - SapI (1439) PciI (1555) BseYI (1859) pFA6a-natMX6 3704 bp
PvuII  (13)
1 site
C A G C T G G T C G A C
NdeI  (3619)
1 site
C A T A T G G T A T A C

Prolonged incubation with NdeI may lead to removal of additional
nucleotides.
AatII  (3370)
1 site
G A C G T C C T G C A G
ZraI  (3368)
1 site
G A C G T C C T G C A G
SspI  (3252)
1 site
A A T A T T T T A T A A
XmnI  (3047)
1 site
G A A N N N N T T C C T T N N N N A A G
TsoI  (2847)
1 site
T A R C C A ( N ) 9 N N A T Y G G T ( N ) 9

Sticky ends from different TsoI sites may not be compatible.
After cleavage, TsoI can remain bound to DNA and alter its
electrophoretic mobility.
For full activity, add fresh S-adenosylmethionine (SAM).
PvuI  (2818)
1 site
C G A T C G G C T A G C
BmrI  (2488)
1 site
A C T G G G ( N ) 4 N T G A C C C ( N ) 4

The 1-base overhangs produced by BmrI may be hard to ligate.
Sticky ends from different BmrI sites may not be compatible.
Unlike most restriction enzymes, BmrI can cleave DNA in the
absence of magnesium.
AlwNI  (1971)
1 site
C A G N N N C T G G T C N N N G A C

Sticky ends from different AlwNI sites may not be compatible.
PspFI  (1863)
1 site
C C C A G C G G G T C G
HindIII  (17)
1 site
A A G C T T T T C G A A
SalI  (35)
1 site
G T C G A C C A G C T G
AccI  (36)
1 site
G T M K A C C A K M T G

Efficient cleavage with AccI requires ≥13 bp on each side of the
recognition sequence.
Sticky ends from different AccI sites may not be compatible.
BamHI  (41)
1 site
G G A T C C C C T A G G

After cleavage, BamHI-HF™ (but not the original BamHI) can
remain bound to DNA and alter its electrophoretic mobility.
PacI  (56)
1 site
T T A A T T A A A A T T A A T T
AscI  (61)
1 site
G G C G C G C C C C G C G C G G
BglII  (68)
1 site
A G A T C T T C T A G A
BstXI  (115)
1 site
C C A N N N N N N T G G G G T N N N N N N A C C

Sticky ends from different BstXI sites may not be compatible.
BmgBI  (151)
1 site
C A C G T C G T G C A G

This recognition sequence is asymmetric, so ligating blunt ends
generated by BmgBI will not always regenerate a BmgBI site.
Bpu10I  (160)
1 site
C C T N A G C G G A N T C G

Efficient cleavage requires at least two copies of the Bpu10I
recognition sequence.
This recognition sequence is asymmetric, so ligating sticky ends
generated by Bpu10I will not always regenerate a Bpu10I site.
Sticky ends from different Bpu10I sites may not be compatible.
BseRI  (262)
1 site
G A G G A G ( N ) 8 N N C T C C T C ( N ) 8

Sticky ends from different BseRI sites may not be compatible.
BseRI quickly loses activity at 37°C.
Prolonged incubation with BseRI may lead to degradation of the
DNA.
NcoI  (455)
1 site
C C A T G G G G T A C C
AgeI  (485)
1 site
A C C G G T T G G C C A

AgeI quickly loses activity at 37°C, but can be used at 25°C for
long incubations.
XcmI  (528)
1 site
C C A N N N N N N N N N T G G G G T N N N N N N N N N A C C

The 1-base overhangs produced by XcmI may be hard to ligate.
Sticky ends from different XcmI sites may not be compatible.
PpuMI  (539)
1 site
R G G W C C Y Y C C W G G R

Sticky ends from different PpuMI sites may not be compatible.
BbsI  (552)
1 site
G A A G A C N N C T T C T G N N ( N ) 4

Sticky ends from different BbsI sites may not be compatible.
BbsI gradually loses activity when stored at -20°C.
PflFI  (556)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by PflFI may be hard to ligate.
Sticky ends from different PflFI sites may not be compatible.
Tth111I  (556)
1 site
G A C N N N G T C C T G N N N C A G

The 1-base overhangs produced by Tth111I may be hard to ligate.
Sticky ends from different Tth111I sites may not be compatible.
PshAI  (700)
1 site
G A C N N N N G T C C T G N N N N C A G

PshAI quickly loses activity at 37°C, but can be used at 25°C for
long incubations.
NruI  (844)
1 site
T C G C G A A G C G C T
MreI  (856)
1 site
C G C C G G C G G C G G C C G C
KasI  (868)
1 site
G G C G C C C C G C G G
NarI  (869)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the NarI
recognition sequence.
SfoI  (870)
1 site
G G C G C C C C G C G G
PluTI  (872)
1 site
G G C G C C C C G C G G

Efficient cleavage requires at least two copies of the PluTI
recognition sequence.
SphI  (1020)
1 site
G C A T G C C G T A C G
BstAPI  (1022)
1 site
G C A N N N N N T G C C G T N N N N N A C G

Sticky ends from different BstAPI sites may not be compatible.
BsmI  (1222)
1 site
G A A T G C N C T T A C G N

Sticky ends from different BsmI sites may not be compatible.
PmeI  (1269)
1 site
G T T T A A A C C A A A T T T G
Eco53kI  (1276)
1 site
G A G C T C C T C G A G
SacI  (1278)
1 site
G A G C T C C T C G A G
ApoI  (1280)
1 site
R A A T T Y Y T T A A R

ApoI is typically used at 50°C, but is 50% active at 37°C.
EcoRI  (1280)
1 site
G A A T T C C T T A A G
BspDI  (1287)
1 site
A T C G A T T A G C T A
ClaI  (1287)
1 site
A T C G A T T A G C T A
EcoRV  (1294)
1 site
G A T A T C C T A T A G

EcoRV is reportedly more prone than its isoschizomer Eco32I to
delete a base after cleavage.
SpeI  (1304)
1 site
A C T A G T T G A T C A
SfiI  (1317)
1 site
G G C C N N N N N G G C C C C G G N N N N N C C G G

Efficient cleavage requires at least two copies of the SfiI
recognition sequence.
Sticky ends from different SfiI sites may not be compatible.
SacII  (1324)
1 site
C C G C G G G G C G C C

Efficient cleavage requires at least two copies of the SacII
recognition sequence.
HpaI  (1376)
1 site
G T T A A C C A A T T G
BspQI  (1439)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different BspQI sites may not be compatible.
SapI  (1439)
1 site
G C T C T T C N C G A G A A G N N N N

Sticky ends from different SapI sites may not be compatible.
SapI gradually settles in solution, so a tube of SapI should be
mixed before removing an aliquot.
PciI  (1555)
1 site
A C A T G T T G T A C A

PciI is inhibited by nonionic detergents.
BseYI  (1859)
1 site
C C C A G C G G G T C G

After cleavage, BseYI can remain bound to DNA and alter its
electrophoretic mobility.
F1
20-mer  /  50% GC
1 binding site
40 .. 59  =  20 annealed bases
Tm  =  54°C
Forward primer for gene deletion. This primer
includes a BamHI recognition sequence. A
gene-specific sequence should be added at the 5'
end of the primer.
R1
20-mer  /  40% GC
1 binding site
1266 .. 1285  =  20 annealed bases
Tm  =  52°C
Reverse primer for gene deletion or C-terminal
tagging. This primer includes an EcoRI recognition
sequence. A gene-specific sequence should be
added at the 5' end of the primer.
natMX6
113 .. 1235  =  1123 bp
yeast selectable marker conferring nourseothricin
resistance
natMX6
113 .. 1235  =  1123 bp
yeast selectable marker conferring nourseothricin
resistance
AmpR
2375 .. 3235  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 2:  
   2375 .. 3166  =  792 bp
   263 amino acids  =  28.9 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
2375 .. 3235  =  861 bp
286 amino acids  =  31.6 kDa
   Segment 1:  signal sequence  
   3167 .. 3235  =  69 bp
   23 amino acids  =  2.6 kDa
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
AmpR
2375 .. 3235  =  861 bp
286 amino acids  =  31.6 kDa
2 segments
Product: β-lactamase
confers resistance to ampicillin, carbenicillin, and
related antibiotics
ori
1616 .. 2204  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
ori
1616 .. 2204  =  589 bp
high-copy-number ColE1/pMB1/pBR322/pUC origin
of replication
AmpR promoter
3236 .. 3340  =  105 bp
AmpR promoter
3236 .. 3340  =  105 bp
T7 promoter
1340 .. 1358  =  19 bp
promoter for bacteriophage T7 RNA polymerase
T7 promoter
1340 .. 1358  =  19 bp
promoter for bacteriophage T7 RNA polymerase
SP6 promoter
3686 .. 3704  =  19 bp
promoter for bacteriophage SP6 RNA polymerase
SP6 promoter
3686 .. 3704  =  19 bp
promoter for bacteriophage SP6 RNA polymerase
NrsR
457 .. 1032  =  576 bp
191 amino acids  =  20.6 kDa
Product: nourseothricin acetyltransferase
confers resistance to nourseothricin
NrsR
457 .. 1032  =  576 bp
191 amino acids  =  20.6 kDa
Product: nourseothricin acetyltransferase
confers resistance to nourseothricin
TEF promoter
113 .. 456  =  344 bp
Ashbya gossypii TEF promoter
TEF promoter
113 .. 456  =  344 bp
Ashbya gossypii TEF promoter
TEF terminator
1038 .. 1235  =  198 bp
Ashbya gossypii TEF terminator
TEF terminator
1038 .. 1235  =  198 bp
Ashbya gossypii TEF terminator
Try SnapGene and create your own beautiful maps

Individual Sequences & Maps

SnapGene offers the fastest and easiest way to plan, visualize, and document your molecular biology procedures.

Priced accessibly so that everyone in your lab can have a license.

Learn More...

SnapGene Viewer is a versatile tool for creating and sharing richly annotated sequence files. It opens many common file formats.

Free! Because there should be no barriers to seeing your data.

Learn More...

The map, notes, and annotations on this page and in the sequence/map file are copyrighted material. This material may be used without restriction by academic, nonprofit, and governmental entities, except that the source must be cited as "www.snapgene.com/resources". Commercial entities must contact GSL Biotech LLC for permission and terms of use.

Copyright © 2016 GSL Biotech LLC | Site Map | Privacy | Legal Disclaimers   Subscribe to Our Newsletter